Population pharmacokinetic analysis from phase I and phase II studies of the humanized monovalent antibody, MetMAb, in patients with advanced solid tumors von Bai, S., Xin, Y., Jin, D., Kaur, S., Nijem, I., Bothos, J. G., Peterson, A. C., Patel, P. H.

Volltext

Safety data and patterns of progression in met diagnostic subgroups in OAM4558g; A phase II trial evaluating MetMAb in combination with erlotinib in advanced NSCLC von Vashishtha, A., Patel, P. H., Yu, W., Bothos, J. G., Simpson, J., Maneatis, T., Doessegger, L., Peterson, A. C., Clement-Duchene, C., Robinet, G., Krzakowski, M., Blumenschein, G. R., Goldschmidt, J. H., Daniel, D. B., Spigel, D. R.

Volltext

Phase Ib dose-escalation study of MetMAb, a monovalent antagonist antibody to the receptor MET, in combination with bevacizumab in patients with locally advanced or metastatic soli... von Moss, R. A., Bothos, J. G., Filvaroff, E., Merchant, M., Eppler, S., Yu, W., Harris, K., Scott, P., Mehnert, J. M., Patel, P. H.

Volltext

A phase 1 multicenter, open-label, dose-escalation and dose-expansion study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, immunogenicity, and antitumor... von Fathi, Amir Tahmasb, Donnellan, William Bruce, Lyons, Roger M., Maris, Michael B., Kim, Tae Min, Kim, Won Seog, Schiller, Gary J., Abboud, Camille N., Arellano, Martha Lucia, Cull, Elizabeth H., Yee, Karen W. L., Townsley, Danielle Michelle, Wang, Fujun, Bothos, John G., Yao, Nai-Shun, Salles, Gilles A.

Volltext

Crystal Structure of a Human Mob1 Protein: Toward Understanding Mob-Regulated Cell Cycle Pathways von Stavridi, Elena S, Harris, Kimberly G, Huyen, Yentram, Bothos, John, Verwoerd, Peter-Mark, Stayrook, Steve E, Pavletich, Nikola P, Jeffrey, Philip D, Luca, Francis C

Volltext

Inactivating mutations targeting the chfr mitotic checkpoint gene in human lung cancer von MARIATOS, George, BOTHOS, John, ZACHARATOS, Panayotis, SUMMERS, Matthew K, SCOLNICK, Daniel M, KITTAS, Christos, HALAZONETIS, Thanos D, GORGOULIS, Vassilis G

Volltext

Abstract 4717: Final results from the Phase I study of MetMAb, a monovalent antagonist antibody to the receptor Met, dosed as single agent and in combination with bevacizumab in pa... von Moss, Rebecca A., Bothos, John G., Patel, Premal H., Peterson, Amy C., Eppler, Steve, Bai, Shuang, Nijem, Ihsan, Desnoyers, Luc, Kaur, Surinder, Zha, Jiping, Yu, Wei, Simpson, Joe, Ratain, Mark J., Tan, Antoinette R., Stein, Mark N., Mehnert, Janice M., Salgia, Ravi

Volltext